imatinib mesylate has been researched along with Disease, Pulmonary in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (72.73) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cortes, J; Malhotra, R; Mauro, M; Saglio, G; Steegmann, JL; Ukropec, JA; Wallis, NT | 1 |
| De Langhe, E; Hillen, A; Himmelreich, U; Lories, RJ; Poelmans, J; Vande Velde, G; Vanoirbeek, J | 1 |
| Guo, RP; Guo, ZX; Lao, XM; Li, JQ; Wang, GH; Ye, ZY; Zhang, YQ | 1 |
| Bacigalupo, A; Balduzzi, A; Cimminiello, M; Gabrielli, A; Gini, G; Leoni, P; Locatelli, F; Mordini, N; Olivieri, A; Raimondi, R; Sanna, A; Zecca, M | 1 |
| Ahlborn, R; Buchholz, S; Diedrich, H; Eder, M; Ganser, A; Kamal, H; Stadler, M | 1 |
| Fox, J; Haston, CK; Thomas, DM | 1 |
| Akin, C; Cools, J; Gilliland, DG; Klion, AD; Law, MA; Metcalfe, DD; Noel, P; Nutman, TB | 1 |
| Han, MK; Horowitz, JC; Moore, BB; Thannickal, VJ; Vittal, R; Zhang, H | 1 |
| Gross, WL; Hellmich, B; Holl-Ulrich, K | 1 |
| Berneburg, M; Bitzer, M; Metzler, G; Müller-Hermelink, HK; Röcken, M; Weyrauch, S; Yazdi, AS | 1 |
| Kano, Y | 1 |
2 review(s) available for imatinib mesylate and Disease, Pulmonary
| Article | Year |
|---|---|
[Hypereosinophilic syndrome--recent developments in diagnosis and treatment].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Glucocorticoids; Humans; Hypereosinophilic Syndrome; Hypersensitivity; Imatinib Mesylate; Immunosuppressive Agents; Interferon-alpha; Lung Diseases; Neoplasms; Parasitic Diseases; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Tumor Necrosis Factor-alpha; Vasculitis | 2007 |
[Adverse drug reactions induced by molecular target therapy].
Topics: Anaphylaxis; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzamides; Cetuximab; Communicable Diseases; ErbB Receptors; Etanercept; Fusion Proteins, bcr-abl; Gefitinib; Humans; Imatinib Mesylate; Immunoglobulin G; Infliximab; Lung Diseases; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Quinazolines; Receptors, Tumor Necrosis Factor; Skin Diseases; Tumor Necrosis Factor-alpha | 2007 |
2 trial(s) available for imatinib mesylate and Disease, Pulmonary
| Article | Year |
|---|---|
Imatinib for refractory chronic graft-versus-host disease with fibrotic features.
Topics: Adolescent; Adult; Benzamides; Child; Female; Fibrosis; Graft vs Host Disease; Humans; Imatinib Mesylate; Intestinal Diseases; Lung Diseases; Male; Middle Aged; Pilot Projects; Piperazines; Pyrimidines; Remission Induction; Salvage Therapy; Skin Diseases; Survival Analysis; Treatment Outcome | 2009 |
Limited efficacy of imatinib in severe pulmonary chronic graft-versus-host disease.
Topics: Adult; Benzamides; Chronic Disease; Female; Graft vs Host Disease; Humans; Imatinib Mesylate; Lung Diseases; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pilot Projects; Piperazines; Prospective Studies; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Salvage Therapy; Treatment Outcome; Young Adult | 2009 |
7 other study(ies) available for imatinib mesylate and Disease, Pulmonary
| Article | Year |
|---|---|
Cardiovascular and pulmonary adverse events in patients treated with BCR-ABL inhibitors: Data from the FDA Adverse Event Reporting System.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Antineoplastic Agents; Benzamides; Cardiovascular Diseases; Dasatinib; Databases, Factual; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Logistic Models; Lung Diseases; Middle Aged; Piperazines; Product Surveillance, Postmarketing; Pyrimidines; Thiazoles; United States; United States Food and Drug Administration; Young Adult | 2015 |
Longitudinal micro-CT provides biomarkers of lung disease that can be used to assess the effect of therapy in preclinical mouse models, and reveal compensatory changes in lung volume.
Topics: Animals; Biomarkers; Bleomycin; Cryptococcosis; Disease Models, Animal; Fibrosis; Imatinib Mesylate; Inflammation; Lung; Lung Diseases; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Pulmonary Aspergillosis; X-Ray Microtomography | 2016 |
A gastrointestinal stromal tumor of the jejunum associated with intrahepatic cholangiocarcinoma and pulmonary hamartoma: a case report.
Topics: Antineoplastic Agents; Benzamides; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Gastrointestinal Stromal Tumors; Hamartoma; Humans; Imatinib Mesylate; Jejunal Neoplasms; Lung Diseases; Male; Middle Aged; Piperazines; Protein-Tyrosine Kinases; Pyrimidines | 2009 |
Imatinib therapy reduces radiation-induced pulmonary mast cell influx and delays lung disease in the mouse.
Topics: Animals; Benzamides; Female; Gene Expression Regulation; Imatinib Mesylate; Lung; Lung Diseases; Mast Cells; Mice; Piperazines; Platelet-Derived Growth Factor; Pyrimidines; Radiation Dosage; Radiation Injuries, Experimental | 2010 |
Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness.
Topics: Adolescent; Adult; Aged; Amino Acid Sequence; Base Sequence; Benzamides; Biopsy; Bone Marrow; Chromosomes, Human, Pair 4; Endomyocardial Fibrosis; Eosinophils; Female; Fibrosis; Gene Deletion; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Leukocytes, Mononuclear; Lung Diseases; Male; Mast Cells; Mastocytosis; Middle Aged; Molecular Sequence Data; mRNA Cleavage and Polyadenylation Factors; Myeloproliferative Disorders; Oncogene Proteins, Fusion; Piperazines; Prognosis; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Reverse Transcriptase Polymerase Chain Reaction; RNA; Serine Endopeptidases; Splenomegaly; Tryptases; Vitamin B 12 | 2003 |
Effects of the protein kinase inhibitor, imatinib mesylate, on epithelial/mesenchymal phenotypes: implications for treatment of fibrotic diseases.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Benzamides; Bleomycin; Blotting, Western; Bromodeoxyuridine; Caspase 3; Cell Line, Tumor; Cells, Cultured; Collagen; DNA, Single-Stranded; Dose-Response Relationship, Drug; Epithelial Cells; Fibroblasts; Fibrosis; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Immunohistochemistry; Indicators and Reagents; Injections, Intraperitoneal; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Diseases; Mesenchymal Stem Cells; Mice; Phenotype; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Signal Transduction | 2007 |
Lymphomatoid granulomatosis induced by imatinib-treatment.
Topics: Aged, 80 and over; Antineoplastic Agents; Benzamides; Female; Humans; Imatinib Mesylate; Liver Neoplasms; Lung Diseases; Lymphomatoid Granulomatosis; Piperazines; Pyrimidines; Skin Diseases | 2007 |